Internal Medicine, Infectious Disease · Hartford, CT
NPI
1235221326
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
6
Medicare group memberships
Hospitals
3
Hospital affiliations
80 Seymour Street, Hartford Hospital Infectious Disease
Hartford, CT, 06102
Phone (860) 545-2878
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
616 services
Medicare patients, 2024
233
Average age 74
Drug cost, 2024
$845K
631 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie A Wright was code 99232 (hospital e&m - subsequent), 362 times for 149 patients. In total Stephanie A Wright billed 616 services in 11 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 362 | 149 | $63.14 | $23K |
| 99222 Hospital E&M - Initial | Facility | 163 | 157 | $104.85 | $17K |
| 99213 Office E&M - Established | Facility | 32 | 25 | $50.50 | $1,616 |
| 99214 Office E&M - Established | Facility | 17 | 13 | $72.66 | $1,235 |
| 99221 Hospital E&M - Initial | Facility | 15 | 14 | $60.51 | $908 |
By year: 2022 $40K for 863 services; 2023 $48K for 701 services; 2024 $46K for 616 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie A Wright prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 63 prescriptions and refills. In total Stephanie A Wright wrote 631 Medicare prescriptions that cost $845K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 63 | 63 | Under 11 | $258K |
| Amoxicillin Generic | 35 | 52 | Under 11 | $333 |
| Cefpodoxime Proxetil Generic | 31 | 33 | Under 11 | $5,799 |
| Descovy Emtricitabine/Tenofov Alafenam | 31 | 31 | Under 11 | $74K |
| Ritonavir Generic | 28 | 30 | Under 11 | $4,468 |
| Emtricitabine Generic | 24 | 24 | Under 11 | $9,133 |
| Tivicay Dolutegravir Sodium | 24 | 24 | Under 11 | $54K |
| Ceftriaxone Ceftriaxone Sodium | 21 | 21 | Under 11 | $342 |
| Cefazolin Sodium Generic | 21 | 21 | Under 11 | $582 |
| Ertapenem Ertapenem Sodium | 20 | 20 | Under 11 | $7,603 |
| Doxycycline Hyclate Generic | 20 | 20 | Under 11 | $660 |
| Minocycline Hcl Generic | 17 | 17 | Under 11 | $284 |
| Juluca Dolutegravir/Rilpivirine | 16 | 16 | Under 11 | $58K |
| Dovato Dolutegravir Sodium/Lamivudine | 15 | 15 | Under 11 | $46K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 15 | 15 | Under 11 | $62K |
Brand drugs: 264 claims; generic drugs: 367 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Stephanie A Wright were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.